Lab-grown ‘ghost hearts' work to solve organ transplant shortage by combining a cleaned-out pig heart with a patient’s own stem cells

Scientist Doris Taylor explains how she and her team are creating bioengineered human hearts in their lab with the goal of one day eliminating the need for heart transplants.

Doris Taylor, Regenerative Medicine Lecturer, University of New Hampshire • conversation
Aug. 10, 2023 • ~9 min

Including race in clinical algorithms can both reduce and increase health inequities – it depends on what doctors use them for

Biased algorithms in health care can lead to inaccurate diagnoses and delayed treatment. Deciding which variables to include to achieve fair health outcomes depends on how you approach fairness.

Anirban Basu, Professor of Health Economics, University of Washington • conversation
May 26, 2023 • ~11 min

Helping the liver regenerate itself could give patients with end-stage liver disease a treatment option besides waiting for a transplant

Liver transplant waitlists can range from 30 days to over five years. Developing treatments that spur liver regeneration could help reduce demand for scarce organs.

Satdarshan Monga, Professor of Pathology and Medicine, University of Pittsburgh Health Sciences • conversation
Oct. 14, 2022 • ~7 min

Organs from genetically engineered pigs may help shorten the transplant wait list

Recent successes putting genetically modified pig organs into people have brought xenotransplantation back into the spotlight.

David Kaczorowski, Associate Professor of Cardiothoracic Surgery, University of Pittsburgh Health Sciences • conversation
March 11, 2022 • ~9 min

How the airline industry recovers from COVID-19 could determine who gets organ transplants

As policymakers weigh financial aid for the airline industry, they have an opportunity to help make the US organ transplantation system more equitable at the same time.

Ronghuo Zheng, Assistant Professor of Accounting, University of Texas at Austin • conversation
Sept. 28, 2020 • ~7 min

/

1